Is a complete DRIO research report available?

No complete published report is available for DarioHealth Corp. (DRIO) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

DarioHealth Corp. (DRIO)

NASDAQ: DRIO · USD

$7.50

+0.02 (+0.3%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-29 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first DRIO analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	54.8M
Revenue (ttm)	21.2M
Net income (ttm)	-41.8M
EPS (ttm)	-$8.29
Shares out	7.3M
Volume	7,100
Beta	1.09
Price target	$18.5	+146.8%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 21.2M
Net income (ttm): -41.8M
EPS (ttm): -$8.29
Market cap: 54.8M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All DRIO indicators

Market & fundamental data

Available fields

217

Groups with data

Currency

USD

Showing 217 of 217 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001533998
Company name	DarioHealth Corp.
Country	United States
Country code	US
Cusip	23725P308
Employees	165
Employees Change	-37%
Employees Change Percent	-18.32
Enterprise value	$66.6M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Health Information Services
Industry PE Fwd	29.23
Isin	US23725P3082
Last refreshed	2026-07-29
Market cap	$54.8M
Market cap category	Micro-Cap
Price	$7.5
Price currency	USD
Rev Per Employee	128,430.3x
Sector	Healthcare
Sector PE	45.13
Sector PE Fwd	23.9
Sic	3841
Symbol	DRIO
Website	https://www.dariohealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-76.2%
EV Sales Forward	2.33x
EV/Sales	3.14x
FCF yield	-46.41%
P/B ratio	0.88x
P/S ratio	2.59x
PS Forward	1.92x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-163.06%
EBITDA Margin	-151.71%
Gross margin	61.13%
Gross Profit	$13M
Gross Profit Growth	-33.42%
Gross Profit Growth Q	-29.01%
Gross Profit Growth3 Y	-0.98%
Gross Profit Growth5 Y	32.35%
Net Income	$-41.8M
Net Income Growth Quarters	2%
Net Income Growth Years	0%
Pretax Margin	-191.57%
Profit Margin	-192.23%
Profit Per Employee	$-253,116
ROA	-19.73
Roa5y	-37.25
ROCE	-36.79
ROE	-59.87
Roe5y	-84.3
ROIC	-21.79

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-42.15%
Cagr1y	-42.47%
Cagr3y	-52.55%
Cagr5y	-51.88%
EPS Growth Quarters	3
EPS Growth Years	4
Revenue Growth	-24.41x
Revenue Growth Q	-17.3x
Revenue Growth Years	0x
Revenue Growth3 Y	-7.37x
Revenue Growth5 Y	17.39x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.19
Assets	$103.3M
Cash	$20M
Current Assets	$28.7M
Current Liabilities	$9.4M
Debt	$31.8M
Debt Equity	$0.51
Equity	$62.4M
Interest Coverage	-8.29
Liabilities	$40.9M
Long Term Assets	$74.5M
Long Term Liabilities	$31.5M
Net Cash	$-11.8M
Net Cash By Market Cap	$-21.54
Net Debt Equity	$0.19
Tangible Book Value	$-10.5M
Tangible Book Value Per Share	$-1.44
WACC	10.29

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.07
Inventory Turnover	1.87
Net Working Capital	$-257,000
Quick ratio	2.57
Working Capital	$19.4M
Working Capital Turnover	$1.09

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-92.7%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-99.58%
1Y total return	-42.45%
200-day SMA	9.92
3Y total return	-89.32%
50-day SMA	7.24
50-day SMA vs 200-day SMA	50under200
5Y total return	-97.42%
All Time High	111,600.3
All Time High Change	-99.99%
All Time High Date	2013-05-20
All Time Low	5.85
All Time Low Change	28.23%
All Time Low Date	2026-06-25
ATR	0.67
Beta	1.09
Beta1y	-0.41
Beta2y	0.47
Ch YTD	-34.14
High	7.89
High52	17.74
High52 Date	2025-10-01
High52ch	-57.76%
Low	7.01
Low52	5.85
Low52 Date	2026-06-25
Low52ch	28.23%
Ma50ch	3.57%
Price vs 200-day SMA	-24.45%
RSI	55.1
RSI Monthly	34.67
RSI Weekly	42.81
Sharpe ratio	-0.09x
Sortino ratio	-0.09
Total Return	-92.7%
Tr YTD	-34.14
Tr1m	6.62%
Tr1w	7.07%
Tr3m	1.01%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	4
Analyst Count Top	1
Analyst Price Target Top	$11
Analyst Ratings	Buy
Analyst Ratings Top	Hold
Earnings EPS Estimate	$-0.84
Earnings Revenue Estimate	5,974,400x
Earnings Revenue Estimate Growth	11.28x
Operating Income	$-34.6M
Operating margin	-163.1
Price target	$18.5
Price Target Change	$147
Price Target Change Top	$46.77

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	5,228,310%
Float Percent	71.5%
Net Borrowing	185,000
Shares Insiders	19.97%
Shares Institutions	4.72%
Shares Out	7,312,398
Shares Qo Q	-16.79%
Shares Yo Y	92.7%
Short Float	1.45%
Short Ratio	5.34
Short Shares	1.04

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-33.9M
Adjusted OCF	-33,757,000
Average Volume	20,524.7x
Bv Per Share	8.55
CAPEX	$-142,000
Ch10y	-99.58
Ch1m	6.62
Ch1w	7.07
Ch1y	-42.45
Ch3m	1.01
Ch3y	-89.32
Ch5y	-97.42
Ch6m	-32.29
Change	0.33%
Change From Open	3.24
Close	7.47
Days Gap	-2.81
Depreciation Amortization	2,406,000
Dollar Volume	53,214.5
Earnings Date	2026-08-13
Earnings Time	bmo
EBIT	$-34.6M
EBITDA	$-32.1M
EPS	$-8.29
F Score	2
FCF	$-25.4M
FCF EV Yield	-38.18x
FCF Per Share	$-3.48
Financing CF	17,498,000
Fiscal Year End	December
Founded	2,011
Goodwill	57,427,000
Income Tax	$140,000
Investing CF	-5,137,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-13
Last Report Date	2026-03-31
Last Split Date	2025-08-28
Last Split Type	Reverse
Last10k Filing Date	2026-03-19
Ma150	8.8
Ma150ch	-14.81%
Ma20	7.09
Ma20ch	5.73%
Net CF	-12,877,000
Next Earnings Date	2026-08-11
Open	7.26
Optionable	No
Position In Range	55.11
Post Close	7.5
Postmarket Change Percent	1.27
Postmarket Price	$7.59
Ppne	1,118,000
Price Date	2026-07-28
Relative Volume	0.35x
Revenue	21,191,000x
SBC By Revenue	39.94x
Share Based Comp	8,464,000
Tax By Revenue	0.66x
Tr6m	-32.29%
Us State	New York
Volume	7,100
Z Score	-6.13

DarioHealth Corp. (DRIO)

Coverage state: Market snapshot only — no published research

Generate the first DRIO analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · DRIO

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All DRIO indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on DRIO

Frequently asked questions